Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Samsung Biologics holds 11th Annual General Meeting of Shareholders 2022-03-29 09:42
VolitionRx Limited Schedules Full Fiscal Year 2021 Earnings Conference Call and Business Update 2022-03-29 04:25
Viva Biotech Announced 2021 Annual Results: Revenue Increased by 201.9% YoY, CRO Business Revenue Maintained Rapid Growth with an Increase of 68.7% 2022-03-29 00:49
Clarity's US-based Cu-64 SAR-bisPSMA trial in prostate cancer opens for recruitment 2022-03-28 21:06
First-ever integrated EEG and neurotherapeutics device iSyncWave wins the 2022 Red Dot Design Award 2022-03-28 20:00
Tigermed Reports Strong 2021 Full-Year Results 2022-03-28 19:10
At the 2022 AAD Annual Meeting, Senhwa Presents Positive Initial Data from Clinical Trial of Silmitasertib Used to Treat Patients with Advanced Basal Cell Carcinoma 2022-03-28 19:00
InnoCare Announces Approval of Clinical Trial of TYK2 JH2 Allosteric Inhibitor ICP-488 in China 2022-03-28 10:48
Kintor Pharma Announces 2021 Business Progress and Annual Results 2022-03-26 01:23
CCTV+: Peng Liyuan addresses World Tuberculosis Day video conference 2022-03-25 11:04
Harbour BioMed Reports Full Year 2021 Financial Results: Empower Value Creation with Global Innovation Capabilities 2022-03-25 10:22
CHINA LIFE INSURANCE COMPANY LIMITED ANNOUNCES 2021 ANNUAL RESULTS (H SHARES) 2022-03-24 22:39
New clinical trial collaboration for Cu-64 SAR-bisPSMA in prostate cancer 2022-03-24 21:08
Orion Health to deliver the world's largest health information exchange in Saudi Arabia 2022-03-24 02:00
CARsgen 2021 Annual Results: Steady Advancement in Innovative CAR T Products and Technologies 2022-03-23 20:50
CARsgen Announces First Patient Enrollment in the Confirmatory Phase II Clinical Trial of CT041 in China 2022-03-23 20:50
Smartee Raises US$ 80 Million in Series D Funding 2022-03-23 20:40
Waterdrop Inc. Announces Fourth Quarter and Fiscal Year 2021 Unaudited Financial Results 2022-03-23 15:40
InnoCare Releases 2021 Annual Results and Business Highlights 2022-03-23 08:08
VivaVision Biotech Announces Positive Topline Results of VVN001 in the Phase 2 Clinical Study for the Treatment of Dry Eye Disease 2022-03-23 08:00
1 156 157 158 159 160 801